Colifoam (hydrocortisone acetate rectal foam): Supply issue
Hydrocortisone acetate rectal foam (Colifoam) has been out of stock since early 2019. We are advised that resupply is expected mid-2022.
The supplier advises that the Colifoam is unlikely to be resupplied before mid-2022. The supplier advised us of this in December 2021. We continue to work closely with the Colifoam supplier to re-establish supply.
Alternative product: Cortifoam
Mylan have sourced a hydrocortisone product from the US, called Cortifoam (pharmacode 2608707).
This was listed in the Schedule from 1 June 2021.
Cortifoam is not Medsafe-approved. It must be prescribed and supplied under section 29 of the Medicines Act.
Clinect had previously sourced an alternative agent, prednisolone sodium – rectal foam 20 mg per dose (brand name: Essential Prednisolone). This was listed in the Pharmaceutical Schedule on 1 October 2020.
Essential Prednisolone is not approved for use in New Zealand by Medsafe. It must be supplied under section 29 of the Medicines Act. We apologise for any inconvenience this causes.